Boston Scientific Corp <BSX.N>: Citigroup cuts target price to $61 from $70
BSX•Related News
Marcus Q2 FY26 net earnings more than doubled to $15.8 million; revenue rises 12.5% to $231.7 million
MCS•
HNI Q2 FY26 GAAP EPS drops 31% to $0.70; net sales more than double to $1.5 billion
HNI•
FTI Consulting Q2 profit misses on higher direct costs
FCN•
Hilton Grand Vacations Q2 profit misses on construction deferrals
HGV•
Baxter raises annual profit forecast on strong demand for IV solutions
BAX•